EP4225035A1 - Antimicrobial facemask - Google Patents

Antimicrobial facemask

Info

Publication number
EP4225035A1
EP4225035A1 EP21787494.0A EP21787494A EP4225035A1 EP 4225035 A1 EP4225035 A1 EP 4225035A1 EP 21787494 A EP21787494 A EP 21787494A EP 4225035 A1 EP4225035 A1 EP 4225035A1
Authority
EP
European Patent Office
Prior art keywords
facemask
surfactant
facemask according
salt
carbons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21787494.0A
Other languages
German (de)
French (fr)
Inventor
Robert GROS
Mark Wilkinson
Paul Wight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BMG British Medical Group Ltd
Original Assignee
BMG British Medical Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BMG British Medical Group Ltd filed Critical BMG British Medical Group Ltd
Publication of EP4225035A1 publication Critical patent/EP4225035A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A41D13/1192—Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A01N59/20—Copper
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B23/00—Filters for breathing-protection purposes
    • A62B23/02—Filters for breathing-protection purposes for respirators
    • A62B23/025—Filters for breathing-protection purposes for respirators the filter having substantially the shape of a mask
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D39/00—Filtering material for liquid or gaseous fluids
    • B01D39/14—Other self-supporting filtering material ; Other filtering material
    • B01D39/16—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • B01D39/1607—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous
    • B01D39/1623—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous of synthetic origin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D39/00—Filtering material for liquid or gaseous fluids
    • B01D39/14—Other self-supporting filtering material ; Other filtering material
    • B01D39/16—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • B01D39/18—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being cellulose or derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0442—Antimicrobial, antibacterial, antifungal additives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0464—Impregnants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0471—Surface coating material
    • B01D2239/0492—Surface coating material on fibres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/06—Filter cloth, e.g. knitted, woven non-woven; self-supported material
    • B01D2239/0604—Arrangement of the fibres in the filtering material
    • B01D2239/0622—Melt-blown
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/06—Filter cloth, e.g. knitted, woven non-woven; self-supported material
    • B01D2239/0604—Arrangement of the fibres in the filtering material
    • B01D2239/0627—Spun-bonded
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/06—Filter cloth, e.g. knitted, woven non-woven; self-supported material
    • B01D2239/065—More than one layer present in the filtering material

Definitions

  • JP2011042615 claims the antiviral properties of masks made from specific methacrylate polymers with copper ions.
  • the present invention identifies certain biocides that are suitable for depositing on fibres (for example polypropylene, polyethylene, polyester, nylon or cellulose) that may be used to construct PPE masks, and demonstrates their antimicrobial properties.
  • the present invention provides an antimicrobial mask comprising certain biocides, in conjunction with certain surfactants.
  • the present invention also provides the use of the facemask as Personal Protective Equipment (PPE) i.e. exclusively to protect the user from infection.
  • PPE Personal Protective Equipment
  • the antimicrobial mask comprises at least one layer of nonwoven fabric, for example meltblown or spunbond formed polypropylene, polyethylene, polyester, cellulose or nylon, onto which is deposited the antimicrobial formulation.
  • the mask is a composite layered mask i.e. multi-layered.
  • Biocides are selected from aqueous soluble copper salts, or organic acids, or a combination of both.
  • Surfactants are selected from zwitterionic surfactants or alkyl sulfate surfactants or alkyl sulfate salt surfactants.
  • the zwitterionic surfactant is a charge separated zwitterionic surfactant, i.e. the positive and negative charge is separated by an alkylene chain at least one carbon atom in length.
  • the positive and negative charge may be separated by a Ci-Cioalkylene.
  • Suitable zwitterionic surfactants may have a sulfobetaine type structure or a betaine type structure.
  • a betaine in chemistry is any neutral chemical compound with a positively charged cationic functional group, such as a quaternary ammonium or phosphonium cation (generally: onium ions) that bears no hydrogen atom and with a negatively charged functional group such as a carboxylate group (or for a “sulfobetaine”, a sulfonate group) that may not be adjacent to the cationic site.
  • a positively charged cationic functional group such as a quaternary ammonium or phosphonium cation (generally: onium ions) that bears no hydrogen atom and with a negatively charged functional group such as a carboxylate group (or for a “sulfobetaine”, a sulfonate group) that may not be adjacent to the cationic site.
  • Betaine type structures also known as carboxylated quaternary amines, are known in the art.
  • Ri is a Ce-C2oalkyl
  • R2 and R3 are each independently selected from Ci-ealkyl which is optionally substituted by hydroxy, halo or sulfonate; and n is an integer from 1 to 10.
  • Such betaine type surfactants are known to the skilled person and exemplified by surfactants such as Empigen BB (a 30% aqueous solution of N,N-dimethyl-N-dodecylglycine betaine).
  • Sulfobetaine type structures are known in the art.
  • Preferred sulfobetaine type structures have the general formula: wherein:
  • R4 is a Ce-C2oalkyl
  • R5 and Re are each independently selected from Ci-ealkyl which is optionally substituted by hydroxy, halo or sulfonate; and m is an integer from 1 to 10.
  • Ci-ealkyl which is optionally substituted by hydroxy, halo or sulfonate
  • m is an integer from 1 to 10.
  • R4 is a Cs-Ciealkyl
  • the zwitterionic surfactant comprises an alkyl chain of between 8 and 16 carbons.
  • the zwitterionic surfactant has a betaine type structure, preferably with quaternary alkyl at the nitrogen i.e. N-quaternary alkyl glycine.
  • the zwitterionic surfactant has a sulfobetaine type structure, preferably lauryl sulfobetaine.
  • Preferred zwitterionic surfactants include lauryl sulfobetaine and N,N-dimethyl-N- dodecylglycine betaine.
  • the most preferred zwitterionic surfactant is N,N-dimethyl-N- dodecylglycine betaine.
  • the non-woven fabric is cellulosic.
  • the non-woven fabric facemask can comprise or consist essentially of cellulosic fibres, preferably at least 50 % by weight.
  • the copper salt may be present in the active formulation in a concentration amount of 0.25 to 10 % wt/wt, preferably 0.5 to 5 % wt/wt.
  • the surfactant may be present in a concentration amount of 0.05 to 5 % wt/wt, preferably 0.1 to 3 % wt.
  • the organic acid where included may be present in a concentration amount of 0.1 to 5 % wt/wt, preferably 0.2 to 3 % wt/wt.
  • the invention therefore provides a process for production of a facemask as defined herein, wherein an active formulation of the water soluble copper salt and surfactant is applied to the non-woven fabric as a solution in water, preferably with the following concentration amounts: a) copper salt at 0.25 - 10 % wt/wt, preferably 0.5 - 5 % wt/wt b) surfactant at 0.05 - 5 % wt/wt, preferably 0.1 - 3 % wt/wt, and optionally when included c) organic acid 0.1 - 5 % wt/wt, preferably 0.2 - 3 % wt/wt.
  • zwitterionic betaine surfactants such as dimethyl dodecylglycine betaine (CAS 66455-29- 6) or lauryl sulfobetaine (CAS 14933-08-5) did not cause precipitation, and gave a homogeneous solution suitable for coating non-woven fabric.
  • zwitterionic betaine surfactants such as dimethyl dodecylglycine betaine (CAS 66455-29- 6) or lauryl sulfobetaine (CAS 14933-08-5) did not cause precipitation, and gave a homogeneous solution suitable for coating non-woven fabric.
  • the structurally related sodium dodecyl sulfate also gave an acceptable solution for coating.
  • alkyl includes both straight and branched chain alkyl groups and analogues thereof.
  • alkylene is an alkyl group that is positioned between and serves to connect two other chemical groups.
  • “Ci-Cealkylene” means a linear saturated divalent hydrocarbon radical of one to six carbon atoms or a branched saturated divalent hydrocarbon radical of three to six carbon atoms, for example, methylene, ethylene, propylene, 2-methylpropylene, pentylene, and the like.
  • Copper sulfate (0.25 g) and citric acid (0.10 g) were dissolved in 24.65 g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added.
  • the bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.
  • Copper sulfate (0.25 g), sodium dodecyl sulfate (0.05 g) and citric acid (0.10 g) were dissolved in 24.60 g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.
  • a 4 cm disc of the sample prepared in Example 4 was inoculated with a 0.1 ml presentation of either Staphylococcus aureus (“Staph a”) or Escherichia coli (“E coli”). After 1 h at 37 °C, a reduction of > 5 Log was achieved for both Staph a and E coli.
  • Staph a Staphylococcus aureus
  • E coli Escherichia coli
  • Copper sulfate (0.25 g), sodium dodecyl sulfate (0.05 g), citric acid (0.10 g) and Lonzabac 12.30 (N'-O-aminopropyll-N'-dodecylpropane- I J-diamine)) (0.1g) were dissolved in 24.4g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Textile Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Biomedical Technology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Nonwoven Fabrics (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to an antimicrobial facemask, use of the antimicrobial facemask and a process for manufacture of the facemask.

Description

ANTIMICROBIAL FACEMASK
FIELD OF INVENTION
The present invention relates to an antimicrobial facemask, use of the antimicrobial facemask and a process for manufacture of the facemask.
BACKGROUND OF THE INVENTION
Recently, the global pandemic caused by the SARS-CoV-2 virus has highlighted the need for effective Personal Protective Equipment (PPE), both in social and professional environments. The protection of users afforded by the mask can prevent their infection with a virus, which could have negative health outcomes for the individual and wider negative impacts on society.
Facemasks are typically made up of multiple layers. These layers can be made from a variety of materials such as polypropylene, polyester or cellulose. A filtration element may trap infective agents such as bacterial and viruses, but unless they are rapidly killed they may grow and become a further contaminating source.
W02004088029 discloses a paper mask with copper ions for viral inactivation.
WO2009146412 reports an antiviral mask comprising copper ions. The examples illustrate a requirement to chemically activate the fabric to bind the actives.
WO2010138426 details a mask for decreasing the transmission of pathogens. It is limited to polypropylene non-wovens. The claimed formulation as applied specifically includes polyvinyl alcohol, and polyethylene sorbitol as a non-ionic surfactant. The treated layer is specified to be an inner layer within a composite mask structure.
JP2010024587 claims the use of organic acid from 7 to 20 carbons for an antiviral masks. It claims the use of anionic surfactants.
JP2011042615 claims the antiviral properties of masks made from specific methacrylate polymers with copper ions.
CN111206417 discloses an antimicrobial cellulose fabric made by deposition of copper salts from alcoholic solutions. WO201 1040035 discloses particles of low solubility copper iodide bound to mask fabric via the requirement of a silane binder.
W02012130117 claims a mask targeted to decrease pathogen transmission via a low pH hydrophilic layer and requires an organic acid.
WO2017073675 details an antiviral mask comprising copper ions made from knitted fabrics.
WO2018074337 disclosed an antimicrobial mask based on inorganic fine particles.
SUMMARY OF THE INVENTION
The present invention identifies certain biocides that are suitable for depositing on fibres (for example polypropylene, polyethylene, polyester, nylon or cellulose) that may be used to construct PPE masks, and demonstrates their antimicrobial properties. In particular, the present invention provides an antimicrobial mask comprising certain biocides, in conjunction with certain surfactants.
The present invention provides an antimicrobial facemask comprising a non-woven fabric or material incorporating a water soluble copper salt and a zwitterionic surfactant or alkylsulfate surfactant. The alkylsulfate surfactant may also be an alkylsulfate salt surfactant. “Incorporating” can include the concepts of coated, impregnated and dyed.
The present invention further provides a process for treating a fabric suitable for a facemask construction with an aqueous solution of the desired formulation. The present invention therefore provides process for production of the facemask, wherein an active formulation of the water soluble copper salt and zwitterionic or alkylsulfate or salt surfactant is applied to the non-woven fabric as a solution in water.
The present invention also provides the use of the facemask as Personal Protective Equipment (PPE) i.e. exclusively to protect the user from infection. DETAILED DESCRIPTION OF THE INVENTION
The antimicrobial mask comprises at least one layer of nonwoven fabric, for example meltblown or spunbond formed polypropylene, polyethylene, polyester, cellulose or nylon, onto which is deposited the antimicrobial formulation. Preferably the mask is a composite layered mask i.e. multi-layered. Biocides are selected from aqueous soluble copper salts, or organic acids, or a combination of both. Surfactants are selected from zwitterionic surfactants or alkyl sulfate surfactants or alkyl sulfate salt surfactants.
The present invention takes advantage of the antimicrobial power of copper ions to protect users, but with increased efficacy from a novel formulation including zwitterionic surfactant or alkylsulfate or salt surfactant. When in a composite layered mask form, the water soluble copper salt and zwitterionic or alkylsulfate or salt surfactant are incorporated in the outer layer or an inner layer or both of the composite layered mask.
Preferably the copper salt has at a solubility of at least 100 g / litre of deionised water at 20 °C. Also preferred is wherein the copper salt is copper sulfate.
Preferably the zwitterionic surfactant is not an amine oxide.
Preferably, the zwitterionic surfactant is a charge separated zwitterionic surfactant, i.e. the positive and negative charge is separated by an alkylene chain at least one carbon atom in length. The positive and negative charge may be separated by a Ci-Cioalkylene.
Suitable zwitterionic surfactants may have a sulfobetaine type structure or a betaine type structure.
A betaine in chemistry is any neutral chemical compound with a positively charged cationic functional group, such as a quaternary ammonium or phosphonium cation (generally: onium ions) that bears no hydrogen atom and with a negatively charged functional group such as a carboxylate group (or for a “sulfobetaine”, a sulfonate group) that may not be adjacent to the cationic site. Betaine type structures, also known as carboxylated quaternary amines, are known in the art.
Preferred betaine type structures have the general formula: wherein:
Ri is a Ce-C2oalkyl;
R2 and R3 are each independently selected from Ci-ealkyl which is optionally substituted by hydroxy, halo or sulfonate; and n is an integer from 1 to 10.
Preferably:
Ri is a Cs-Ciealkyl;
R2 and R3 are methyl, n is an integer from 1 to 5, optionally 1 to 3.
Such betaine type surfactants are known to the skilled person and exemplified by surfactants such as Empigen BB (a 30% aqueous solution of N,N-dimethyl-N-dodecylglycine betaine).
Sulfobetaine type structures are known in the art. Preferred sulfobetaine type structures have the general formula: wherein:
R4 is a Ce-C2oalkyl;
R5 and Re are each independently selected from Ci-ealkyl which is optionally substituted by hydroxy, halo or sulfonate; and m is an integer from 1 to 10. Preferably:
R4 is a Cs-Ciealkyl;
Rs and Re are methyl, m is an integer from 1 to 5, optionally 1 to 3.
Preferably the zwitterionic surfactant comprises an alkyl chain of between 8 and 16 carbons.
It is also preferred when the zwitterionic surfactant has a betaine type structure, preferably with quaternary alkyl at the nitrogen i.e. N-quaternary alkyl glycine.
It is also preferred when the zwitterionic surfactant has a sulfobetaine type structure, preferably lauryl sulfobetaine.
Preferred zwitterionic surfactants include lauryl sulfobetaine and N,N-dimethyl-N- dodecylglycine betaine. The most preferred zwitterionic surfactant is N,N-dimethyl-N- dodecylglycine betaine.
Alternatively preferable is an alkylsulfate surfactant or its salt comprising an alkyl chain of between 8 and 16 carbons, preferably sodium dodecylsulfate.
The facemask may also incorporate an organic carboxylic acid, preferably having between 3 and 7 carbons. Preferred acids include propionic acid, citric acid or lactic acid. Alternatively, the facemask may comprise no organic acid.
The facemask may also incorporate an additional biocide. Suitable biocides may be selected from Lonzabac 12.30 (i.e. N1-(3-aminopropyl)-N1-dodecylpropane-l,3-diamine) and Di decyl dimethyl ammonium chi ori de .
Preferably the non-woven fabric is cellulosic. In this respect the non-woven fabric facemask can comprise or consist essentially of cellulosic fibres, preferably at least 50 % by weight.
For manufacture of the facemask an active formulation of the water soluble copper salt and surfactant can be applied to the non-woven fabric as a solution in water. When in a composite layered mask form, the active formulation is applied to the outer layer or an inner layer or both of the composite layered mask.
The copper salt may be present in the active formulation in a concentration amount of 0.25 to 10 % wt/wt, preferably 0.5 to 5 % wt/wt. The surfactant may be present in a concentration amount of 0.05 to 5 % wt/wt, preferably 0.1 to 3 % wt. The organic acid where included may be present in a concentration amount of 0.1 to 5 % wt/wt, preferably 0.2 to 3 % wt/wt.
The invention therefore provides a process for production of a facemask as defined herein, wherein an active formulation of the water soluble copper salt and surfactant is applied to the non-woven fabric as a solution in water, preferably with the following concentration amounts: a) copper salt at 0.25 - 10 % wt/wt, preferably 0.5 - 5 % wt/wt b) surfactant at 0.05 - 5 % wt/wt, preferably 0.1 - 3 % wt/wt, and optionally when included c) organic acid 0.1 - 5 % wt/wt, preferably 0.2 - 3 % wt/wt.
The active formulation may further comprise an additional biocide, in a concentration of 0.01 to 5% wt/wt, preferably 0.05 to 0.5% wt/wt. Suitable biocides may be selected from Lonzabac 12.30 (N1-(3-aminopropyl)-N1-dodecylpropane-l,3-diamine) and Didecyldimethylammonium chloride.
Surface active agents can significantly alter the surface energy of polymeric materials, aiding wetting and adhesion. However, this presents a key technical hurdle. When requiring a water soluble copper presentation to enable deposition onto fabric, many surfactants are unsatisfactory. Anionic surfactants (for example sodium dodecylbenzenesulfonate) have very low and insufficient solubility in solutions of copper sulfate. Amine oxide surfactants such as dimethyl dodecylamine N-oxide or N,N-dimethyloleyl N-oxide (CAS 14351-50-9) are also unacceptable, causing precipitation from copper sulfate solutions. Unexpectedly, it was found that zwitterionic betaine surfactants, such as dimethyl dodecylglycine betaine (CAS 66455-29- 6) or lauryl sulfobetaine (CAS 14933-08-5) did not cause precipitation, and gave a homogeneous solution suitable for coating non-woven fabric. In addition we made the unexpected discovery that in sharp contrast to sodium dodecylbenzenesulfonate, the structurally related sodium dodecyl sulfate also gave an acceptable solution for coating. In this specification the term “alkyl” includes both straight and branched chain alkyl groups and analogues thereof. References to individual alkyl groups such as “propyl” are specific for the straight chain version only and references to individual branched chain alkyl groups such as “isopropyl” are specific for the branched chain version only. For example, “Ci-Cealkyl” includes Ci-C4alkyl, Ci-Csalkyl, propyl, isopropyl and t-butyl.
An “alkylene” group is an alkyl group that is positioned between and serves to connect two other chemical groups. Thus, “Ci-Cealkylene” means a linear saturated divalent hydrocarbon radical of one to six carbon atoms or a branched saturated divalent hydrocarbon radical of three to six carbon atoms, for example, methylene, ethylene, propylene, 2-methylpropylene, pentylene, and the like.
The present invention will now be illustrated, but in no way limited, by reference to the following examples.
Example 1 - Fabric preparation
Copper sulfate (0.25 g) and citric acid (0.10 g) were dissolved in 24.65 g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.
Example 2 - Fabric preparation
Copper sulfate (0.25 g), sodium dodecyl sulfate (0.05 g) and citric acid (0.10 g) were dissolved in 24.60 g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.
Example 3 - Fabric preparation
Copper sulfate (0.25 g), lauryl sulfobetaine (CAS 14933-08-5) (0.05 g) and citric acid (0.10 g) were dissolved in 24.60 g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried. Example 4 - Fabric preparation
Copper sulfate (0.25 g), Empigen BB (0.10 g) and citric acid (0.10 g) were dissolved in 24.55 g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.
Empigen BB is a 30% aqueous solution of N,N-dimethyl-N-dodecylglycine betaine.
Example 5 - Microbiology performance of above fabrics
A 4 cm disc of the sample prepared in Example 4 was inoculated with a 0.1 ml presentation of either Staphylococcus aureus (“Staph a”) or Escherichia coli (“E coli”). After 1 h at 37 °C, a reduction of > 5 Log was achieved for both Staph a and E coli.
Example 6 - Fabric preparation
Copper sulfate (0.25 g), sodium dodecyl sulfate (0.05 g), citric acid (0.10 g) and Lonzabac 12.30 (N'-O-aminopropyll-N'-dodecylpropane- I J-diamine)) (0.1g) were dissolved in 24.4g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.
Example 7 - Fabric preparation
Copper sulfate (0.25 g), Empigen BB (0.1g), and Lonzabac 12.30 ((N1-(3-aminopropyl)-N1- dodecylpropane-l,3-diamine)) (0.1g) were dissolved in 24.55g water, and a 18 x 18 cm square of non-woven cellulose fabric (suitable for facemask construction) added. The bath was heated in a 50 °C oven for 10 min, then the fabric removed and air dried.

Claims

1) An antimicrobial facemask comprising a non-woven fabric incorporating a water soluble copper salt and surfactant, wherein the surfactant is a zwitterionic surfactant or an alkylsulfate surfactant or an alkyl sulfate salt surfactant.
2) The facemask according to claim 1, wherein: a) the zwitterionic surfactant comprises an alkyl chain of between 8 and 16 carbons and has a sulfobetaine type structure or a betaine type structure; or b) the alkylsulfate or its salt comprises an alkyl chain of between 8 and 16 carbons.
3) The facemask according to claim 1 or 2, wherein the copper salt has at a solubility of at least 100 g / litre of deionised water at 20 °C.
4) The facemask according to any one of the preceding claims, wherein the copper salt is copper sulfate.
5) The facemask according to any one of the preceding claims, wherein the zwitterionic surfactant comprises an alkyl chain of between 8 and 16 carbons.
6) The facemask according to any one of the preceding claims, wherein the zwitterionic surfactant has a sulfobetaine type structure, preferably lauryl sulfobetaine.
7) The facemask according to any of claims 1 to 5, wherein the zwitterionic surfactant has a betaine type structure, preferably based on a trialkyl glycine.
8) The facemask according to any of claims 1 to 5, wherein the zwitterionic surfactant is N,N- dimethyl-N-dodecylglycine betaine.
9) The facemask according to any of claims 1 to 4, wherein the alkylsulfate or its salt comprises an alkyl chain of between 8 and 16 carbons, preferably wherein the alkylsulfate is sodium dodecylsulfate.
10) A facemask according to any one of the preceding claims also incorporating an organic carboxylic acid.
9 11) A facemask according to claim 10, wherein the organic carboxylic acid has between 3 and 7 carbons.
12) A facemask according to claim 10, wherein the organic acid is any of propionic acid, citric acid or lactic acid.
13) A facemask according to any one of the preceding claims, further comprising Nx-(3- aminopropy^-Nkdodecylpropane-l^-diamine or Didecyldimethylammonium chloride.
14) A facemask according to any one of the preceding claims, wherein the facemask is a composite layered mask, optionally wherein the water soluble copper salt and surfactant are incorporated in the outer layer and/or an inner layer of the composite layered mask.
15) A facemask according to any one of the preceding claims, wherein the non-woven fabric is cellulosic, preferably wherein the non-woven fabric consists essentially of cellulosic fibres, preferably at least 50 % by weight.
16) Use of a facemask according to any one of the preceding claims as Personal Protective Equipment.
17) A process for production of a facemask according to any one of the preceding claims, wherein an active formulation of a water soluble copper salt and surfactant is applied to a nonwoven fabric as a solution in water, preferably with the following concentration amounts: a) copper salt at 0.25 - 10 % wt/wt, preferably 0.5 - 5 % wt/wt b) surfactant at 0.05 - 5 % wt/wt, preferably 0.1 - 3 % wt/wt, and optionally when included c) organic acid 0.1 - 5 % wt/wt, preferably 0.2 - 3 % wt/wt.
EP21787494.0A 2020-10-07 2021-10-06 Antimicrobial facemask Pending EP4225035A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20200498.2A EP3981252A1 (en) 2020-10-07 2020-10-07 Antimicrobial facemask
PCT/GB2021/052579 WO2022074384A1 (en) 2020-10-07 2021-10-06 Antimicrobial facemask

Publications (1)

Publication Number Publication Date
EP4225035A1 true EP4225035A1 (en) 2023-08-16

Family

ID=72801341

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20200498.2A Withdrawn EP3981252A1 (en) 2020-10-07 2020-10-07 Antimicrobial facemask
EP21787494.0A Pending EP4225035A1 (en) 2020-10-07 2021-10-06 Antimicrobial facemask

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20200498.2A Withdrawn EP3981252A1 (en) 2020-10-07 2020-10-07 Antimicrobial facemask

Country Status (5)

Country Link
US (1) US20240016245A1 (en)
EP (2) EP3981252A1 (en)
JP (1) JP2023544737A (en)
AU (1) AU2021357511A1 (en)
WO (1) WO2022074384A1 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040197386A1 (en) 2003-04-01 2004-10-07 The Cupron Corporation Disposable paper-based hospital and operating theater products
WO2009146412A1 (en) 2008-05-30 2009-12-03 Filligent Limited Protective face mask
JP5126745B2 (en) 2008-07-22 2013-01-23 国立大学法人鳥取大学 Antiviral agent and antiviral sheet
MY188369A (en) * 2009-05-29 2021-12-06 Filligent Ltd Composition for use in decreasing the transmission of human pathogens
JP2011042615A (en) 2009-08-20 2011-03-03 Daiwabo Holdings Co Ltd Antiviral substance, antiviral fiber and antiviral fiber structure
IN2012DN02357A (en) 2009-09-30 2015-08-21 Nbc Meshtec Inc
US20120272967A1 (en) 2011-03-02 2012-11-01 Filligent Limited Mask Structure and Compositions for Use in Decreasing the Transmission of Human Pathogens
CN107708459A (en) 2015-10-30 2018-02-16 株式会社吉姆威 Antiviral property health gauze mask
JP6689613B2 (en) * 2016-01-29 2020-04-28 株式会社Ｃｓｌ Antibacterial and antiviral composition for textiles and textile products
WO2018074337A1 (en) 2016-10-17 2018-04-26 株式会社Ｎｂｃメッシュテック Mask
CN111206417A (en) 2020-03-02 2020-05-29 青岛明月生物医用材料有限公司 Antiviral layer prepared from copper-containing sodium carboxymethylcellulose fiber and application thereof
CN112056313B (en) * 2020-08-31 2021-11-16 中国科学院地球环境研究所 Method for aqueous phase synthesis of nano Cu-MOF (copper-metal organic framework) bacteriostatic agent

Also Published As

Publication number Publication date
JP2023544737A (en) 2023-10-25
EP3981252A1 (en) 2022-04-13
AU2021357511A1 (en) 2023-06-08
WO2022074384A1 (en) 2022-04-14
US20240016245A1 (en) 2024-01-18

Similar Documents

Publication Publication Date Title
TWI687250B (en) Wash-durable face mask with antimicrobial properties and/or improved washability
US7942957B2 (en) Air filter having antimicrobial property
US20120258157A1 (en) Process for the Treatment of Synthetic Textiles with Cationic Biocides
EP1272037B1 (en) Antimicrobial and antiviral polymeric materials
US8999357B2 (en) Methods and compositions for biocidal treatments
AU2007276218B2 (en) Anti-viral face mask and filter material
ES2327369T3 (en) DISINFECTING COMPOUNDS THAT PROVIDE PROLONGED BIOCIDE ACTION.
US20040247653A1 (en) Antimicrobial and antiviral polymeric materials and a process for preparing the same
CA2604020C (en) Antimicrobial solution comprising a metallic salt and a surfactant
US20110154557A1 (en) Antimicrobial apparel and fabric and coverings
KR20130094686A (en) Antimicrobial treatment of synthetic nonwoven textiles
CN114908562B (en) Antibacterial antiviral agent, preparation method thereof and antibacterial antiviral mask
AU2021357511A1 (en) Antimicrobial facemask
WO2018085564A2 (en) 3-in-one fabric conditioners and softeners comprising antimicrobial agents
US20120087962A1 (en) Novel article
US11549199B2 (en) Active apparel and fabric and coverings
US20140030304A1 (en) Process for the Treatment of Synthetic Textiles with Cationic Biocides
CN106832267B (en) A kind of guanidine copolymer and preparation method thereof
US20220056371A1 (en) 3-in one fabric conditioners and softeners comprising antimicrobial agents
US20240043618A1 (en) Antimicrobial compositions
US20240315241A1 (en) Antimicrobial polymeric composition
EP3876737A1 (en) Tris-substituted biguanide compounds and their uses
MXPA98001246A (en) Compositions bioci

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230504

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)